Endoscopic Assisted Calcium Electroporation in Esophageal Cancer
Status:
Not yet recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
In this pilot study, patients with non-curable esophageal cancer will be treated with
endoscopic assisted calcium electroporation (CaEP). CaEP is a novel cancer treatment where
intratumoral injection with calcium is combined with locally applied electrical pulses, in
order to increase calcium influx which leads to tumor necrosis.
It is hypothesized that:
- Endoscopic assisted CaEP is a safe and feasible procedure in patients with non-curable
esophageal cancer
- CaEP debulks the tumor, facilitating the patient's ability to eat and drink
In this single-arm pilot study, eight patients will be treated.